Which has better valuation and earnings, HIND or COCH?

Vyome has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vyome $320K 45.19 -$10.26M -$12.27 N/A Envoy Medical $234K 217.73 -$23.76M -$1.01 N/A

Is HIND or COCH more profitable?

Vyome has a net margin of 0.00% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Vyome N/A -203.92% -134.16% Envoy Medical -9,875.64% N/A -177.92%

Do analysts rate IINN or HIND?

Vyome has a consensus price target of $15.00, indicating a potential upside of 628.16%. Given Vyome's stronger consensus rating and higher possible upside, analysts clearly believe Vyome is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Vyome 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has stronger earnings and valuation, IINN or HIND?

Vyome has higher revenue and earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $289K 109.60 -$13.22M N/A N/A Vyome $320K 45.19 -$10.26M -$12.27 N/A

Is IINN or HIND more profitable?

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Inspira Technologies OXY B.H.N. N/A N/A N/A Vyome N/A -203.92% -134.16%

Do analysts rate QTEX or HIND?

Vyome has a consensus target price of $15.00, indicating a potential upside of 628.16%. Given Vyome's stronger consensus rating and higher probable upside, analysts plainly believe Vyome is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Vyome 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has higher earnings & valuation, QTEX or HIND?

Vyome has higher revenue and earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $290K 109.23 -$13.22M N/A N/A Vyome $320K 45.19 -$10.26M -$12.27 N/A

Is QTEX or HIND more profitable?

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Inspira Technologies OXY B.H.N. N/A N/A N/A Vyome N/A -203.92% -134.16%

Which has higher valuation & earnings, MDAI or HIND?

Spectral AI has higher revenue and earnings than Vyome. Spectral AI is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Spectral AI $19.65M 2.66 -$7.57M -$0.53 N/A Vyome $320K 45.19 -$10.26M -$12.27 N/A

Is MDAI or HIND more profitable?

Vyome has a net margin of 0.00% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Spectral AI -85.58% N/A -72.97% Vyome N/A -203.92% -134.16%

Do analysts prefer POCI or HIND?

Vyome has a consensus price target of $15.00, suggesting a potential upside of 628.16%. Given Vyome's stronger consensus rating and higher probable upside, analysts clearly believe Vyome is more favorable than Precision Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Vyome 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has higher valuation and earnings, POCI or HIND?

Precision Optics has higher revenue and earnings than Vyome. Precision Optics is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Precision Optics $19.09M 2.46 -$5.78M -$0.63 N/A Vyome $320K 45.19 -$10.26M -$12.27 N/A

Is POCI or HIND more profitable?

Vyome has a net margin of 0.00% compared to Precision Optics' net margin of -17.03%. Precision Optics' return on equity of -37.47% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Precision Optics -17.03% -37.47% -19.96% Vyome N/A -203.92% -134.16%

Vyome (HIND) Competitors

$2.06 -0.08 (-3.74%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$2.06 +0.00 (+0.24%)

As of 07/24/2026 04:10 PM Eastern

Compare

HIND vs. COCH, IINN, QTEX, MDAI, and POCI

Should you buy Vyome stock or one of its competitors? MarketBeat compares Vyome with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Vyome include Envoy Medical (COCH), Inspira Technologies OXY B.H.N. (IINN), Inspira Technologies OXY B.H.N. (QTEX), Spectral AI (MDAI), and Precision Optics (POCI). These companies are all part of the "medical equipment" industry.

How does Vyome compare to Envoy Medical?

Vyome (NASDAQ:HIND) and Envoy Medical (NASDAQ:COCH) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

Vyome has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$320K	45.19	-$10.26M	-$12.27	N/A
Envoy Medical	$234K	217.73	-$23.76M	-$1.01	N/A

Vyome currently has a consensus price target of $15.00, indicating a potential upside of 628.16%. Envoy Medical has a consensus price target of $2.50, indicating a potential upside of 277.24%. Given Vyome's stronger consensus rating and higher probable upside, research analysts clearly believe Vyome is more favorable than Envoy Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Vyome has a beta of 1.49, indicating that its stock price is 49% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.88, indicating that its stock price is 88% more volatile than the broader market.

In the previous week, Envoy Medical had 2 more articles in the media than Vyome. MarketBeat recorded 3 mentions for Envoy Medical and 1 mentions for Vyome. Vyome's average media sentiment score of 1.87 beat Envoy Medical's score of 0.06 indicating that Vyome is being referred to more favorably in the media.

Company	Overall Sentiment
Vyome	Very Positive
Envoy Medical	Neutral

22.1% of Vyome shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 33.0% of Vyome shares are owned by company insiders. Comparatively, 7.1% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Vyome has a net margin of 0.00% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vyome	N/A	-203.92%	-134.16%
Envoy Medical	-9,875.64%	N/A	-177.92%

Summary

Vyome beats Envoy Medical on 11 of the 16 factors compared between the two stocks.

How does Vyome compare to Inspira Technologies OXY B.H.N.?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Vyome (NASDAQ:HIND) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Vyome	N/A	-203.92%	-134.16%

Vyome has a consensus price target of $15.00, indicating a potential upside of 628.16%. Given Vyome's stronger consensus rating and higher possible upside, analysts clearly believe Vyome is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 22.1% of Vyome shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Comparatively, 33.0% of Vyome shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Vyome has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$289K	109.60	-$13.22M	N/A	N/A
Vyome	$320K	45.19	-$10.26M	-$12.27	N/A

In the previous week, Inspira Technologies OXY B.H.N. and Inspira Technologies OXY B.H.N. both had 1 articles in the media. Vyome's average media sentiment score of 1.87 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Vyome is being referred to more favorably in the news media.

Company	Overall Sentiment
Inspira Technologies OXY B.H.N.	Neutral
Vyome	Very Positive

Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its stock price is 116% more volatile than the broader market. Comparatively, Vyome has a beta of 1.49, indicating that its stock price is 49% more volatile than the broader market.

Summary

Vyome beats Inspira Technologies OXY B.H.N. on 8 of the 12 factors compared between the two stocks.

How does Vyome compare to Inspira Technologies OXY B.H.N.?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Vyome (NASDAQ:HIND) are both small-cap manufacturing companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.

Vyome has a consensus target price of $15.00, indicating a potential upside of 628.16%. Given Vyome's stronger consensus rating and higher probable upside, analysts plainly believe Vyome is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Inspira Technologies OXY B.H.N. has a beta of 4.2, meaning that its share price is 320% more volatile than the broader market. Comparatively, Vyome has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market.

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Vyome	N/A	-203.92%	-134.16%

Vyome has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$290K	109.23	-$13.22M	N/A	N/A
Vyome	$320K	45.19	-$10.26M	-$12.27	N/A

In the previous week, Inspira Technologies OXY B.H.N. had 3 more articles in the media than Vyome. MarketBeat recorded 4 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Vyome. Vyome's average media sentiment score of 1.87 beat Inspira Technologies OXY B.H.N.'s score of 0.23 indicating that Vyome is being referred to more favorably in the news media.

Company	Overall Sentiment
Inspira Technologies OXY B.H.N.	Neutral
Vyome	Very Positive

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 22.1% of Vyome shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 33.0% of Vyome shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Vyome beats Inspira Technologies OXY B.H.N. on 8 of the 13 factors compared between the two stocks.

How does Vyome compare to Spectral AI?

Spectral AI (NASDAQ:MDAI) and Vyome (NASDAQ:HIND) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

67.1% of Spectral AI shares are held by institutional investors. Comparatively, 22.1% of Vyome shares are held by institutional investors. 13.7% of Spectral AI shares are held by company insiders. Comparatively, 33.0% of Vyome shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Vyome has a net margin of 0.00% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-85.58%	N/A	-72.97%
Vyome	N/A	-203.92%	-134.16%

In the previous week, Spectral AI and Spectral AI both had 1 articles in the media. Vyome's average media sentiment score of 1.87 beat Spectral AI's score of 0.94 indicating that Vyome is being referred to more favorably in the news media.

Company	Overall Sentiment
Spectral AI	Positive
Vyome	Very Positive

Spectral AI has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market. Comparatively, Vyome has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market.

Spectral AI has higher revenue and earnings than Vyome. Spectral AI is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$19.65M	2.66	-$7.57M	-$0.53	N/A
Vyome	$320K	45.19	-$10.26M	-$12.27	N/A

Spectral AI presently has a consensus price target of $4.00, suggesting a potential upside of 143.90%. Vyome has a consensus price target of $15.00, suggesting a potential upside of 628.16%. Given Vyome's stronger consensus rating and higher possible upside, analysts plainly believe Vyome is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Vyome beats Spectral AI on 9 of the 15 factors compared between the two stocks.

How does Vyome compare to Precision Optics?

Precision Optics (NASDAQ:POCI) and Vyome (NASDAQ:HIND) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

In the previous week, Precision Optics had 1 more articles in the media than Vyome. MarketBeat recorded 2 mentions for Precision Optics and 1 mentions for Vyome. Vyome's average media sentiment score of 1.87 beat Precision Optics' score of 1.31 indicating that Vyome is being referred to more favorably in the news media.

Company	Overall Sentiment
Precision Optics	Positive
Vyome	Very Positive

Precision Optics has a beta of 0.32, suggesting that its stock price is 68% less volatile than the broader market. Comparatively, Vyome has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market.

Vyome has a net margin of 0.00% compared to Precision Optics' net margin of -17.03%. Precision Optics' return on equity of -37.47% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Precision Optics	-17.03%	-37.47%	-19.96%
Vyome	N/A	-203.92%	-134.16%

Vyome has a consensus price target of $15.00, suggesting a potential upside of 628.16%. Given Vyome's stronger consensus rating and higher probable upside, analysts clearly believe Vyome is more favorable than Precision Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Precision Optics has higher revenue and earnings than Vyome. Precision Optics is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precision Optics	$19.09M	2.46	-$5.78M	-$0.63	N/A
Vyome	$320K	45.19	-$10.26M	-$12.27	N/A

13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 22.1% of Vyome shares are owned by institutional investors. 14.4% of Precision Optics shares are owned by company insiders. Comparatively, 33.0% of Vyome shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Vyome beats Precision Optics on 10 of the 16 factors compared between the two stocks.

Get Vyome News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIND vs. The Competition

Export

Metric	Vyome	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$15.02M	$3.03B	$7.24B	$12.26B
Dividend Yield	N/A	N/A	40.99%	9.79%
P/E Ratio	-0.17	21.41	23.62	23.64
Price / Sales	45.19	16.40	132.14	89.57
Price / Cash	N/A	8.66	165.01	59.64
Price / Book	3.07	5.32	12.77	6.07
Net Income	-$10.26M	$23.43M	$120.21M	$331.99M
7 Day Performance	-4.19%	-4.57%	-0.98%	-0.63%
1 Month Performance	-2.37%	-8.25%	-2.00%	-2.00%
1 Year Performance	N/A	2.05%	9.75%	13.62%

Vyome Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIND Vyome	3.0994 of 5 stars	$2.06 -3.7%	$15.00 +628.2%	N/A	$15.02M	$320K	N/A	50	Positive News
COCH Envoy Medical	3.1869 of 5 stars	$0.72 -4.6%	$2.50 +245.5%	-59.3%	$58.33M	$240K	N/A	34	News Coverage Upcoming Earnings Analyst Forecast Gap Up
IINN Inspira Technologies OXY B.H.N.	0.0131 of 5 stars	$1.50 +1.4%	N/A	-38.1%	$53.92M	$289K	N/A	20	High Trading Volume
QTEX Inspira Technologies OXY B.H.N.	0.6274 of 5 stars	$1.42 -5.3%	N/A	N/A	$53.92M	$290K	N/A	20
MDAI Spectral AI	1.6364 of 5 stars	$1.69 +1.2%	$4.00 +136.7%	-39.5%	$53.15M	$19.65M	N/A	83

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HIND) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Vyome (HIND) Competitors

HIND vs. COCH, IINN, QTEX, MDAI, and POCI

How does Vyome compare to Envoy Medical?

Summary

How does Vyome compare to Inspira Technologies OXY B.H.N.?

Summary

How does Vyome compare to Inspira Technologies OXY B.H.N.?

Summary

How does Vyome compare to Spectral AI?

Summary

How does Vyome compare to Precision Optics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIND vs. The Competition

Vyome Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Vyome (HIND) Competitors

HIND vs. COCH, IINN, QTEX, MDAI, and POCI

How does Vyome compare to Envoy Medical?

Which has better valuation and earnings, HIND or COCH?

Do analysts rate HIND or COCH?

Which has more risk & volatility, HIND or COCH?

Does the media refer more to HIND or COCH?

Do institutionals and insiders have more ownership in HIND or COCH?

Is HIND or COCH more profitable?

Summary

How does Vyome compare to Inspira Technologies OXY B.H.N.?

Is IINN or HIND more profitable?

Do analysts rate IINN or HIND?

Do institutionals and insiders believe in IINN or HIND?

Which has stronger earnings and valuation, IINN or HIND?

Does the media favor IINN or HIND?

Which has more volatility & risk, IINN or HIND?

Summary

How does Vyome compare to Inspira Technologies OXY B.H.N.?

Do analysts rate QTEX or HIND?

Which has more risk and volatility, QTEX or HIND?

Is QTEX or HIND more profitable?

Which has higher earnings & valuation, QTEX or HIND?

Does the media prefer QTEX or HIND?

Do insiders and institutionals believe in QTEX or HIND?

Summary

How does Vyome compare to Spectral AI?

Do institutionals and insiders believe in MDAI or HIND?

Is MDAI or HIND more profitable?

Does the media refer more to MDAI or HIND?

Which has more volatility and risk, MDAI or HIND?

Which has higher valuation & earnings, MDAI or HIND?

Do analysts recommend MDAI or HIND?

Summary

How does Vyome compare to Precision Optics?

Does the media prefer POCI or HIND?

Which has more risk & volatility, POCI or HIND?

Is POCI or HIND more profitable?

Do analysts prefer POCI or HIND?

Which has higher valuation and earnings, POCI or HIND?

Do institutionals & insiders have more ownership in POCI or HIND?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIND vs. The Competition

Vyome Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools